Foamlase

Foamlase™ is a revolutionary vascular treatment solution developed by INTERmedic that combines the efficacy of sclerosant foam with the precision of the BlueScan laser to elevate the performance of varicose vein therapies. This breakthrough technology allows specialists to perform procedures in‑clinic with enhanced safety and comfort, without the need for tumescent anesthesia. Foamlase’s unique synergy enhances the action of sclerosant foam through targeted laser energy, improving penetration and treatment outcomes for venous insufficiencies of various sizes. The result is a more effective, controlled, and comfortable experience for both clinicians and patients, with optimized procedural efficiency and high satisfaction among vascular specialists. Key Benefits: • Enhanced efficacy through the fusion of sclerosant foam and precise laser activation. • In‑clinic procedure without tumescent anesthesia, reducing procedural time and complexity. • Improved patient comfort, making treatments safer and more tolerable. • Versatile application across a range of venous disease presentations. • Represents a significant step forward in modern vascular intervention technologies. Foamlase™ highlights INTERmedic’s commitment to advancing vascular surgery and vein care with cutting‑edge, patient‑friendly solutions that expand the possibilities of minimally invasive treatment.